Watson, B. N. J., Vercoe, R. B., Salmond, G. P. C., Westra, E. R., Staals, R. H. J., & Fineran, P. C. (2019). Type I-F CRISPR-Cas resistance against virulent phages results in abortive infection and provides population-level immunity. Nat Commun.

Watson, Bridget N. J., Reuben B. Vercoe, George P. C. Salmond, Edze R. Westra, Raymond H. J. Staals, and Peter C. Fineran. "Type I-F CRISPR-Cas Resistance against Virulent Phages Results in Abortive Infection and Provides Population-level Immunity." Nat Commun 2019.

Watson, Bridget N. J., et al. "Type I-F CRISPR-Cas Resistance against Virulent Phages Results in Abortive Infection and Provides Population-level Immunity." Nat Commun 2019.